State-of-the-art document on optimal contemporary management of cardiomyopathies

Autores da FMUP
Participantes de fora da FMUP
- Seferovic, PM
- Polovina, M
- Rosano, G
- Bozkurt, B
- Metra, M
- Heymans, S
- Mullens, W
- Bauersachs, J
- Sliwa, K
- de Boer, RA
- Farmakis, D
- Thum, T
- Olivotto, I
- Rapezzi, C
- Linhart, A
- Corrado, D
- Tschöpe, C
- Milinkovic, I
- Genis, AB
- Filippatos, G
- Keren, A
- Asanin, M
- Krljanac, G
- Maksimovic, R
- Skouri, H
- Ben Gal, T
- Volterrani, M
- Abdelhamid, M
- Lopatin, Y
- Chioncel, O
- Coats, AJS
Unidades de investigação
Abstract
Cardiomyopathies represent significant contributors to cardiovascular morbidity and mortality. Over the past decades, a progress has occurred in characterization of the genetic background and major pathophysiological mechanisms, which has been incorporated into a more nuanced diagnostic approach and risk stratification. Furthermore, medications targeting core disease processes and/or their downstream adverse effects have been introduced for several cardiomyopathies. Combined with standard care and prevention of sudden cardiac death, these novel and emerging targeted therapies offer a possibility of improving the outcomes in several cardiomyopathies. Therefore, the aim of this document is to summarize practical approaches to the treatment of cardiomyopathies, which includes the evidence-based novel therapeutic concepts and established principles of care, tailored to the individual patient aetiology and clinical presentation of the cardiomyopathy. The scope of the document encompasses contemporary treatment of dilated, hypertrophic, restrictive and arrhythmogenic cardiomyopathy. It was based on an expert consensus reached at the Heart Failure Association online Workshop, held on 18 March 2021.
Dados da publicação
- ISSN/ISSNe:
- 1388-9842, 1879-0844
- Tipo:
- Review
- Páginas:
- 1899-1922
- DOI:
- 10.1002/ejhf.2979
European Journal of Heart Failure Wiley-Blackwell
Citações Recebidas na Web of Science: 3
Documentos
- Não há documentos
Filiações
Keywords
- Aetiology; Arrhythmogenic cardiomyopathy; Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Management; Mortality; Restrictive cardiomyopathy; Treatment
Proyectos asociados
Loop diuretic suspension in Chronic Heart Failure patients - a retrospective study
Investigador Principal: Brenda Eugénia Carvalho de Moura Cardoso
Estudo Clínico Académico (Loop diuretic) . 2023
Citar a publicação
Seferovic PM,Polovina M,Rosano G,Bozkurt B,Metra M,Heymans S,Mullens W,Bauersachs J,Sliwa K,de Boer RA,Farmakis D,Thum T,Olivotto I,Rapezzi C,Linhart A,Corrado D,Tschöpe C,Milinkovic I,Genis AB,Filippatos G,Keren A,Asanin M,Krljanac G,Maksimovic R,Skouri H,Ben T,Moura B,Volterrani M,Abdelhamid M,Lopatin Y,Chioncel O,Coats A. State-of-the-art document on optimal contemporary management of cardiomyopathies. Eur. J. Heart Fail. 2023. 25(11):p. 1899-1922. IF:18,200. (1).